We checked names on the Advisory Committee on Medicines Scheduling (ACMS) and they are different to those on the international treaty on pandemic prevention and preparedness. The ACMS is under the Health Products Regulation Group of the Dept of Health. The Treaty has the influence of the Dept of Health Strategic Evidence and Research Group with Agastya Bharadwaj leading the team managing Australia’s relationship with the World Health Organization.
Names at the 8 September 2021 ACMS from the link:
Nine members from the Commonwealth, States, ACT and NT:
Dr Jane Cook – Commonwealth
Ms Vivien Bevan – Australian Capital Territory
Mr Peter Gilfedder – New South Wales
Ms Helgi Stone – Northern Territory
Dr Julie Stokes – Queensland
Ms Angela FitzHenry – South Australia
Mr Sam Halliday – Tasmania
Ms Wendy Yang – Victoria
Ms Jane Carpenter – Western Australia
And eight additional members selected through an open invitation process:
1.A/Professor Suzanne Nielsen – NHMRC Career Development Fellow, former WHO advisor
2.Ms Elise Apolloni – Pharmacy Board of Australia
3.Professor Jennifer Martin – University of Newcastle, and Rhodes Scholar
4.Dr Danielle McMullen – current President of the Australian Medical Association (NSW)
5.Associate Professor Bridin Murnion is a practising physician
6.Mr John Stubbs – consumer engagement in healthcare
7.Mrs Julie Viatos – Consumer Healthcare Products Australia
8.A/Professor Michael Ward – University of South Australia.
From the 8 September 2021 ACMS Report the standing and invited observers were:
Dr Tony GILL – Commonwealth Dept. of Health
Adj Prof John SKERRITT – Deputy Secretary, Health Products Regulation Group,
Commonwealth Dept. of Health
Ms Gillian MITCHELL – First Assistant Secretary, Regulatory Practice and Support
Division, Commonwealth Dept. of Health
Mr Benjamin NOYEN – Assistant Secretary, Regulatory Engagement & Planning
Branch, Commonwealth Dept. of Health
PLUS 2 other names blacked out.
PS: At the 8 Sept Meeting of ACMS, Conflict of Interest declarations were received from all members. Other declared conflicts of interest received from unnamed others were discussed and agreed upon that they could be present and fully participate in the committee discussions.